Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mckesson Corp. (MCK)
NYSE:MCK
MCK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$464.42 - $637.51
Previous CloseN/A
Volume137.88K
Average Volume (3M)766.22K
Market Cap
$75.12B
Enterprise Value$81.01B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)27.5
Beta0.48
Next Earnings
May 13, 2025EPS Estimate
9.82Next Dividend Ex-Date
Mar 03, 2025Dividend Yield0.44%
Share Statistics
EPS (TTM)21.82
Shares Outstanding125,326,380
10 Day Avg. Volume887,538
30 Day Avg. Volume766,218
Standard Deviation0.07
R-Squared0.15
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.22
Price to Cash Flow (P/CF)-7.90
P/FCF Ratio0.00
Enterprise Value/Market Cap1.08
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit6.44
Enterprise Value/Ebitda16.36
Forecast
1Y Price Target
$672.50Price Target Upside11.43% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
---
Bulls Say, Bears Say
Bulls Say
AcquisitionsThe proposed acquisition of a majority stake in Prism Vision is expected to be accretive, with plans to replace regional distributors soon after the deal closes.
EarningsUS Pharma showed strong performance with a 19.3% increase in revenue year-over-year, supported by higher volumes in oncology and specialty providers.
Financial PerformanceMcKesson raised its revenue growth guidance to 16%-18% and adjusted EPS guidance slightly upwards, indicating confidence in future performance.
Bears Say
Earnings MissThe negative share reaction relates largely to the Medical F3Q EBIT miss and lowered Medical guidance.
Performance ConcernsA notable step down in Med-Surg performance alongside an operational miss is disappointing and may impact short-term stock performance.
Segment PerformanceThe Med-Surg Solutions segment experienced some weakness due to a slower than average flu/illness season.
---
Ownership Overview
0.08% Insiders
22.68% Mutual Funds
17.46% Other Institutional Investors
39.04% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MCK FAQ
What was Mckesson Corp.’s price range in the past 12 months?
Mckesson Corp. lowest stock price was $464.42 and its highest was $637.51 in the past 12 months.
What is Mckesson Corp.’s market cap?
Mckesson Corp.’s market cap is $75.12B.
When is Mckesson Corp.’s upcoming earnings report date?
Mckesson Corp.’s upcoming earnings report date is May 13, 2025 which is in 81 days.
How were Mckesson Corp.’s earnings last quarter?
Mckesson Corp. released its earnings results on Feb 05, 2025. The company reported $8.03 earnings per share for the quarter, beating the consensus estimate of $7.989 by $0.041.
Is Mckesson Corp. overvalued?
According to Wall Street analysts Mckesson Corp.’s price is currently Undervalued.
Does Mckesson Corp. pay dividends?
Mckesson Corp. pays a Quarterly dividend of $0.709 which represents an annual dividend yield of 0.44%. See more information on Mckesson Corp. dividends here
What is Mckesson Corp.’s EPS estimate?
Mckesson Corp.’s EPS estimate is 9.82.
How many shares outstanding does Mckesson Corp. have?
Mckesson Corp. has 125,326,380 shares outstanding.
What happened to Mckesson Corp.’s price movement after its last earnings report?
Mckesson Corp. reported an EPS of $8.03 in its last earnings report, beating expectations of $7.989. Following the earnings report the stock price went down -1.178%.
Which hedge fund is a major shareholder of Mckesson Corp.?
Currently, no hedge funds are holding shares in MCK
---
McKesson Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$672.50 (11.43% Upside)
$672.50 (11.43% Upside)
Blogger Sentiment
Bullish
MCK Sentiment 91%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 5.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 1.3%
Last 30 Days ▼ 1.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.49%
12-Months-Change
Fundamentals
Return on Equity
51.23%
Trailing 12-Months
Asset Growth
6.87%
Trailing 12-Months
Company Description
Mckesson Corp.
Incorporated in 1833, Texas-based McKesson Corp. provides pharmaceuticals, health information technology, medical supplies, and care management tools. The company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions.
---
MCK Company Deck
---
MCK Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong financial performance with significant revenue and profit growth, driven by strategic acquisitions and expansions in specialty services. Despite challenges in the Medical Surgical segment and some revenue impacts due to formulary changes, the company's raised guidance and strong segment growth indicate a positive outlook.Read More>---
MCK Revenue Breakdown
90.22% U.S. Pharmaceutical
4.57% International
3.66% Medical-Surgical Solutions
1.54% Prescription Technology Solutions
---
MCK Stock 12 Month Forecast
Average Price Target
$672.50
▲(11.43% Upside)
Technical Analysis
Best Analysts Covering MCK
1 Year
1 Year Success Rate
19/21 ratings generated profit
1 Year Average Return
+30.65%
reiterated a buy rating 5 months ago
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 90.48% of your transactions generating a profit, with an average return of +30.65% per trade.
---